Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves first CIRM‑funded gene‑editing therapy for rare immune disorder
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I in children without a matching bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine (CIRM), highlighting the agency’s impact on translational research.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Theolytics, an Oxford‑based biotech, secured an €8 million non‑dilutive Horizon Europe grant to fund its phase 2 OCTOPOD‑IV expansion trial of THEO‑260, a novel oncolytic therapy for advanced ovarian cancer. The grant, awarded after a rigorous review, will finance the phase 2a portion targeting high‑grade serous and endometrioid tumors. International collaborators include the Institute of Cancer Research and Clínica Universidad de Navarra. THEO‑260’s dual action aims to destroy cancer cells and cancer‑associated fibroblasts, addressing a major unmet need in stroma‑rich solid tumors.
In 2025, Europe’s EMA, China’s NMPA, and Japan’s PMDA each granted first‑time approvals for novel large‑molecule therapeutics. Oncology accounted for the largest share of these approvals, while endocrinology—driven largely by GLP‑1‑based agents—was the second biggest category. The approvals span a...
WNBA point guard Erica Wheeler, whose mother died of cervical cancer, has joined Hologic’s “Ultimate Defense” campaign to promote screening, especially among women of color. The campaign highlights that routine Pap and HPV testing have cut U.S. cervical cancer mortality...
VitalHub UK and CEMBooks have formed a partnership to deliver complementary digital tools for NHS operational insight and situational awareness. The collaboration combines VitalHub’s SHREWD system‑level platform with CEMBooks’ department‑focused management suite, allowing structured local capture alongside system‑wide oversight. Both...
Early‑onset colorectal cancer now accounts for about 13% of U.S. cases, with roughly 20,000 new diagnoses each year in patients under 50. The disease is more aggressive, often presenting at later stages because routine screening starts at age 45. Researchers...
Private equity’s expansion into health‑care has sparked a policy debate, but dentistry reveals a more nuanced picture. A recent study with the American Dental Association found that PE‑owned dental practices did not secure higher negotiated insurer rates. Instead, they raised...
In a candid ER column, Dr. George Issa describes the “Blanket Sign”—the tendency of adult patients who bring personal blankets to exhibit psychiatric or drug‑seeking behavior. He recounts a 42‑year‑old woman with chronic abdominal pain, opioid history, and a barrage...
A Stanford‑Harvard NOHARM study evaluated 31 AI systems on 100 real‑world physician consult cases, finding that AMBOSS LiSA 1.0 topped the leaderboard with a 62.3% match to expert‑approved actions. While the leading models outperformed board‑certified internists by over 15 points, all AIs...
Aspire Biopharma has teamed with particle‑engineering specialist Microsize to develop a sublingual powder formulation of alprazolam, aiming for faster anxiety relief than traditional tablets. The partnership leverages Microsize’s micronisation expertise and Pace’s excipient compatibility and stability services to accelerate development....
The episode explores the health dangers of loneliness, citing research that shows people with few close friends face a 25% higher mortality rate over eight years. It references longitudinal studies from Harvard, China, and Sweden, and highlights the Surgeon General’s...
The FDA issued its first botanical drug guidance in 2004 and updated it in 2016, yet only four complex plant‑derived drugs have been approved to date. Ajna Biosciences, led by Joel Stanley, has secured clearance to begin a Phase 2 trial...
Earlier diagnosis can change the trajectory of Alzheimer’s. Yet thousands of people in the UK still live with dementia for years before receiving a formal diagnosis. The signals are often already present in clinical records, they are simply fragmented across...
Vocxi Health has teamed with Forj Medical to shrink its MyBreathPrint breath‑analysis system from a tabletop prototype to a handheld device the size of a deck of cards. The platform leverages graphene‑based nano sensors and AI‑driven algorithms to detect disease‑linked...
Medtronic and GE HealthCare have broadened a multi‑year partnership to embed Medtronic’s pulse oximetry, brain monitoring, capnography and regional oximetry technologies across GE’s bedside, telemetry and ambulatory monitoring platforms. The agreement accelerates integration of next‑generation Nellcor pulse oximetry and BIS...
Extracellular vesicles (EVs) are emerging as a versatile platform for regenerative medicine and targeted drug delivery. Researchers highlight their ability to transfer proteins, RNA, and lipids between cells, mimicking natural signaling pathways. Recent advances in isolation, engineering, and loading techniques...
The UK government announced nearly £48 million in equipment funding to accelerate commercial clinical trials across the NHS. The money will equip 51 NHS trusts and 79 primary‑care organisations with diagnostic tools, scanners and mobile research vans, with 60 % directed to...
Researchers from ETH Zurich, the Friedrich Miescher Institute and the Cantonal Hospital of Lucerne have 3D‑printed elastic ear cartilage that closely replicates natural tissue mechanics. Using patient‑derived cartilage cells embedded in a bio‑ink, they produced ear‑shaped constructs that retained shape...
The UK health‑care sector is rapidly replacing analogue telecare with cloud‑based, data‑driven platforms. In 2026, digital governance, AI‑powered predictive analytics and real‑time monitoring will become core to care delivery. Providers adopting these tools can spot early signs of decline, allocate...
Harrison.ai announced that four AI companies—AIRAmed, Koios Medical, Lunit and Nanox AI—are joining its Open Platform, expanding the catalog of imaging solutions across X‑ray, CT, MRI, mammography and ultrasound. The platform maintains a vendor‑neutral, zero‑mark‑up model, allowing healthcare organizations to...
Pharmaceutical firms are accelerating onshoring efforts, with more than $270 billion pledged for U.S. manufacturing since early 2025 and 80% of global producers weighing domestic or near‑shore options. Legislative moves such as the BIOSECURE Act and incentives like BARDA Project NextGen are...
Sequana Medical reported that five leading U.S. hospitals have implanted its alfapump System since its Q4 2025 launch, including Mount Sinai, University of Pennsylvania, Dartmouth Hitchcock, and University Medical Center of Southern Nevada. The company is actively pursuing approvals to expand...
Hua Medicine announced that its glucokinase activator dorzagliatin, marketed as MYHOMSIS®, received marketing approval from Hong Kong’s Department of Health under the “1+” regulatory pathway. The drug, the world’s first‑in‑class GKA, targets the root cause of glucose dysregulation in Type 2 diabetes...
Maybe it's not new, but that's the first time I saw a digital tourniquet. It is designed to help anyone quickly stop the bleeding. No training required. Just tighten, press, and save a life. This is the line companies like XMetix...
Top officials at the National Institutes of Health (NIH) often serve open‑ended five‑year terms, with many directors remaining in post for a decade or more. Critics argue that such long tenures can stifle innovation, entrench soft power, and limit fresh...
North Bristol NHS Trust performed its 10,000th robotic-assisted surgery, underscoring a decade of minimally invasive growth across multiple specialties. Meanwhile, Alder Hey Children’s NHS Foundation Trust expanded its 360° virtual tour to a full‑hospital map covering 313,585 square feet, helping...
Digital health innovators require structured support systems to move from concept to clinical impact. The article outlines how regulatory navigation, technical mentorship, education, and institutional ecosystems collectively reduce risk and accelerate product readiness. Early integration of quality, compliance, and clinician...
A large retrospective study of over 600,000 U.S. veterans found that patients prescribed GLP-1 receptor agonists for diabetes were 14% less likely to develop new substance-use disorders compared with those on SGLT-2 inhibitors. The analysis also showed 30% fewer drug-related...
MIT engineers have unveiled SAFARI, a biodegradable ingestible sensor that confirms pill ingestion using a bioresorbable Faraday cage and RFID tag. The device activates once the cage dissolves in the gastrointestinal tract and transmits a signal within about ten minutes....
Healthcare providers have poured resources into unified communications platforms such as Microsoft Teams, yet the majority of frontline clinicians remain underserved by devices that cannot survive rigorous hygiene protocols or unreliable wireless coverage. While administrative staff benefit from modern UC...
Employers have layered dozens of digital health point solutions, creating a fragmented benefits landscape that confuses employees and burdens HR teams. Kris Heinzen argues that true value emerges when these tools are woven into a unified network that prioritizes personalization,...
Quantum Surgical, a French robotics and AI specialist, has acquired Miami‑based NeuWave Medical from Johnson & Johnson, creating the Precision IO Group. The combined entity merges Quantum’s Epione platform for robotic‑assisted tumor ablation with NeuWave’s market‑leading microwave ablation devices used...
Merck’s Keytruda remained pharma’s top‑selling drug in 2025, generating $31.7 billion and a 7 % year‑on‑year increase. However, the combined sales of GLP‑1 franchises—Eli Lilly’s tirzepatide line and Novo Nordisk’s semaglutide portfolio—totaled over $36 billion, overtaking Keytruda for the first time. The GLP‑1 market is...
A new Nature study sequenced the whole genomes of 1,364 breast cancers and linked the data to transcriptomics and real‑world treatment outcomes. The analysis showed that genome‑wide signatures such as homologous recombination deficiency, intratumoral heterogeneity, and copy‑number instability correlate with...
ABEL, Westfund Health Insurance, and the Australian Skin Cancer Foundation have launched a national campaign offering free 3D mobile skin scans in regional Australia. The initiative brings world‑first 3D scanning technology directly to communities, removing cost and access barriers. Using...
New Device Detects Brain Waves in Mini Brains Mimicking Early Human Development by @ShellyFan https://t.co/oMMhx9ux8Q https://t.co/6321RBopxf
King's College London researchers found that a chair‑side HbA1c finger‑prick test identified pre‑diabetes or diabetes in more than one‑third of dental patients without prior diagnosis. The study of 911 NHS patients linked higher HbA1c levels to greater severity of gum...
The U.S. Department of Health and Human Services and SAMHSA issued a February 2024 Final Rule that modernizes 42 C.F.R. Part 2, aligning substance‑use‑disorder (SUD) privacy with HIPAA while preserving heightened protections. Effective February 16 2026, the rule permits a single written consent for all treatment,...
The EPA is contesting a Ninth Circuit panel’s view that a district judge overstepped by introducing new scientific studies in a case challenging federal fluoride standards. Food & Water Watch argues the EPA’s optimal fluoridation level poses an unreasonable risk...
Early-stage testicular cancer patients could soon benefit from a blood‑based assay that detects microscopic disease after orchiectomy. The CLIMATE study, led by WEHI and ANZUP, identified the microRNA marker miR‑371 as a reliable predictor of relapse, which occurs in roughly...
Alifor announced a strategic partnership with Piat Public Health to embed implementation science into its AI‑driven clinical workflow platform. The collaboration will launch a six‑month study at General Hospital Lagos’ trauma centre, evaluating whether the system improves documentation, triage consistency,...
Novari Health, a VitalHub company, is rolling out its Medical Imaging Requisition Management (MIRM) and eRequest referral platforms across all Niagara Health sites. The deployment adds an AI‑driven Document AI layer that auto‑populates data, detects multiple referrals, and verifies patient...
The Montreal Heart Institute (MHI) has opened the Centre for Advanced Simulation in Heart Valve Therapy, the first high‑fidelity valve simulation centre in the Americas. Acquired from Simulands, the platform supports training across transcatheter, repair and emerging minimally invasive procedures....
The CHEO Research Institute’s pediatric AI tool, ThinkRare, is moving beyond its home site to McMaster Children’s Hospital, Alberta Children’s Hospital and Stollery Children’s Hospital, marking one of Canada’s first national deployments of a real‑time, clinically embedded AI algorithm. ThinkRare...
EyePoint reported Q4 2025 results, highlighting rapid enrollment of over 900 patients in two pivotal wet AMD Phase 3 trials (Lugano and LUCHIA) with top‑line data expected mid‑2026. The company also initiated Phase 3 DME studies (COMO and CAPREIT) slated for first...
Cross Country Healthcare reported Q4 2018 revenue of $200.9 million, down 9% year‑over‑year, and a net loss of $19.7 million. CEO Kevin Clark, a co‑founder, returned to lead a turnaround, eliminating the COO role and promoting internal leaders. The company...
Sight Sciences reported fourth‑quarter 2025 revenue of $20.4 million, a 7% year‑over‑year increase, driven by $19.7 million from interventional glaucoma and $0.7 million from the newly reimbursed interventional dry‑eye segment. Gross margins remained strong at 87% overall, while operating expenses fell 25% after...
Niagen Bioscience reported Q2 2025 revenue of $31.1 million, a 37% year‑over‑year increase, and lifted full‑year revenue guidance to 22‑27%. Gross margin improved to 65% driven by a higher‑margin sales mix and inventory efficiencies. The company expanded its Niagen Plus clinic...
Ardent Health reported solid volume and revenue growth in Q3 2025, with revenue up 8.8% to $1.58 billion and adjusted EBITDA rising 46% to $143 million. However, the company lowered its full‑year adjusted EBITDA guidance to $530‑$555 million, citing accelerating professional‑fee expenses and...
Viemed Healthcare reported a 14.7% year‑over‑year revenue increase in fiscal Q2 2025, driven entirely by organic growth across its core ventilation, sleep therapy, and resupply segments. Adjusted EBITDA rose 12% to $14.3 million, while SG&A fell to 45.7% of revenue, reflecting...
Brook.ai, led by CEO Oren Nissim, is scaling its remote patient monitoring (RPM) platform to cut hospital readmissions and improve care plan adherence. The company reports over 50% of its hypertension cohort achieving control within ten weeks and a roughly...
